Sosei and Pharmenable expand drug discovery collaboration to include second neurology target
Oct. 10, 2023
Sosei Group Corp. and Pharmenable Therapeutics Ltd. have expanded their collaboration to apply their respective technologies to drive novel drug discovery for a second neurological disease target.
